197 related articles for article (PubMed ID: 35537347)
1. Melatonin relieves Th17/CD4
Liu Y; Chen XQ; Wang F; Cheng B; Zhou G
Int Immunopharmacol; 2022 Aug; 109():108778. PubMed ID: 35537347
[TBL] [Abstract][Full Text] [Related]
2. SLAMF3 promotes Th17 differentiation and is reversed by iguratimod through JAK1/STAT3 pathway in primary Sjögren's syndrome.
Hu P; Cai J; Yang C; Xu L; Ma S; Song H; Yang P
Int Immunopharmacol; 2024 Jan; 126():111282. PubMed ID: 38061117
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of RORγ positive and negative subsets of CD161+CD4+ T cells in primary Sjögren's syndrome.
Zhao L; Nocturne G; Haskett S; Boudaoud S; Lazure T; Le Pajolec C; Mariette X; Mingueneau M; Banerjee D
Rheumatology (Oxford); 2017 Feb; 56(2):303-312. PubMed ID: 27803305
[TBL] [Abstract][Full Text] [Related]
4. Blockade of Th17 response by IL-38 in primary Sjögren's syndrome.
Luo D; Chen Y; Zhou N; Li T; Wang H
Mol Immunol; 2020 Nov; 127():107-111. PubMed ID: 32950755
[TBL] [Abstract][Full Text] [Related]
5. Melatonin: a potential therapeutic approach for the management of primary Sjögren's syndrome.
Liu Y; Tan YQ; Zhou G
Immunol Res; 2023 Jun; 71(3):373-387. PubMed ID: 36715831
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine A Suppresses the Activation of the Th17 Cells in Patients with Primary Sjögren's Syndrome.
Wang K; Shi L; Yu Z; Deng Z; He A; Li S; Liu L
Iran J Allergy Asthma Immunol; 2015 Apr; 14(2):198-207. PubMed ID: 25780886
[TBL] [Abstract][Full Text] [Related]
7. CD4(-)CD8(-) T-cells in primary Sjögren's syndrome: association with the extent of glandular involvement.
Alunno A; Carubbi F; Bistoni O; Caterbi S; Bartoloni E; Bigerna B; Pacini R; Beghelli D; Cipriani P; Giacomelli R; Gerli R
J Autoimmun; 2014 Jun; 51():38-43. PubMed ID: 24461537
[TBL] [Abstract][Full Text] [Related]
8. The role of RORα in salivary gland lesions in patients with primary Sjögren's syndrome.
Weng X; Liu Y; Cui S; Cheng B
Arthritis Res Ther; 2018 Sep; 20(1):205. PubMed ID: 30189901
[TBL] [Abstract][Full Text] [Related]
9. IL-17-producing double-negative T cells are expanded in the peripheral blood, infiltrate the salivary gland and are partially resistant to corticosteroid therapy in patients with Sjögren's syndrome.
Alunno A; Bistoni O; Bartoloni Bocci E; Caterbi S; Bigerna B; Pucciarini A; Tabarrini A; Mannucci R; Beghelli D; Falini B; Gerli R
Reumatismo; 2013 Oct; 65(4):192-8. PubMed ID: 24192564
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory effects of umbilical mesenchymal stem cell-derived exosomes on CD4
Ma D; Wu Z; Zhao X; Zhu X; An Q; Wang Y; Zhao J; Su Y; Yang B; Xu K; Zhang L
Inflammopharmacology; 2023 Aug; 31(4):1823-1838. PubMed ID: 37012581
[TBL] [Abstract][Full Text] [Related]
11. Alterations of CD8
Li H; Zhou Y; Wang P; Wang Y; Feng Y; Zhang Y; Wu Z
Clin Rheumatol; 2023 May; 42(5):1327-1338. PubMed ID: 36609932
[TBL] [Abstract][Full Text] [Related]
12. Increased CD200 levels in peripheral blood mononuclear cells of patients with primary Sjögren's syndrome.
Liu TT; Zeng XP; Gu ML; Deng AM
Int J Rheum Dis; 2020 May; 23(5):654-660. PubMed ID: 32180363
[TBL] [Abstract][Full Text] [Related]
13. Immune responses after influenza vaccination in patients of primary Sjögren's syndrome.
Zhou X; Liu Y; Jin Y; Wang Y; Miao M; Chen J; Cheng Y; Liu Y; He J; Li Z
Rheumatology (Oxford); 2021 Jan; 60(1):224-230. PubMed ID: 32671409
[TBL] [Abstract][Full Text] [Related]
14. Angiogenic T cells in primary Sjögren's syndrome: a double-edged sword?
Alunno A; Ibba-Manneschi L; Bistoni O; Cipriani S; Topini F; Gerli R; Manetti M
Clin Exp Rheumatol; 2019; 37 Suppl 118(3):36-41. PubMed ID: 30336792
[TBL] [Abstract][Full Text] [Related]
15. Increased frequency of CCR7
Wu C; Yang P; Liu H; Xiao W; Zhao L
Cytokine; 2018 Oct; 110():9-17. PubMed ID: 29684636
[TBL] [Abstract][Full Text] [Related]
16. Expression of G
Sun Y; Wang Y; Chen S; Fan G; Zhang J; Dai F; Qian H; Liu Y; Shi G
J Immunol Res; 2018; 2018():8212641. PubMed ID: 29977933
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-146a-5p enhances T helper 17 cell differentiation via decreasing a disintegrin and metalloprotease 17 level in primary sjögren's syndrome.
Wang X; Xin S; Wang Y; Ju D; Wu Q; Qiu Y; Niu X; Liu W; Li J; Ji P
Bioengineered; 2021 Dec; 12(1):310-324. PubMed ID: 33446013
[TBL] [Abstract][Full Text] [Related]
18. IL-2 Inhibition of Th17 Generation Rather Than Induction of Treg Cells Is Impaired in Primary Sjögren's Syndrome Patients.
Luo J; Ming B; Zhang C; Deng X; Li P; Wei Z; Xia Y; Jiang K; Ye H; Ma W; Liu Z; Li H; Yang XP; Dong L
Front Immunol; 2018; 9():1755. PubMed ID: 30150979
[TBL] [Abstract][Full Text] [Related]
19. LncRNA Neat1 positively regulates MAPK signaling and is involved in the pathogenesis of Sjögren's syndrome.
Ye L; Shi H; Yu C; Fu J; Chen C; Wu S; Zhan T; Wang B; Zheng L
Int Immunopharmacol; 2020 Nov; 88():106992. PubMed ID: 33182021
[TBL] [Abstract][Full Text] [Related]
20. Th17 cells in primary Sjögren's syndrome: Pathogenicity and plasticity.
Verstappen GM; Corneth OBJ; Bootsma H; Kroese FGM
J Autoimmun; 2018 Feb; 87():16-25. PubMed ID: 29191572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
